Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal drug therapy

A A Rosenberg1, H L Galan

  • 1Department of Pediatrics, University of Colorado School of Medicine, Denver, USA.

Pediatric Clinics of North America
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Sophisticated prenatal diagnostics enable intrauterine therapies. This review covers drug treatments for fetal and neonatal conditions, with future potential in hematopoietic and genetic therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal outcomes following chronotropic rescue and delayed umbilical cord clamping in fetal complete atrioventricular block with low heart rate.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Blood pressure during pregnancy, neonatal size and altered body composition: the Healthy Start study.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Science and regulation. Congress's attacks on science-based rules.

Science (New York, N.Y.)·2015
Same author

Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.

Journal of perinatology : official journal of the California Perinatal Association·2014
Same author

Increased trophoblast expression of NFAT5/TonEBP in pre-eclamptic placentas and hyperosmolar-treated BeWo cells.

European journal of obstetrics, gynecology, and reproductive biology·2014
Same author

Decreased expression of phosphorylated placental heat shock protein 27 in human and ovine intrauterine growth restriction (IUGR).

Placenta·2014
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Area of Science:

  • Perinatology
  • Fetal Medicine
  • Pharmacology

Background:

  • Advancements in prenatal diagnostic capabilities have expanded treatment options for unborn infants.
  • Surgical and pharmacological interventions are established intrauterine therapies.

Purpose of the Study:

  • To review intrauterine drug therapy for preventing and treating fetal and neonatal diseases.
  • To explore emerging intrauterine treatment modalities.

Main Methods:

  • Literature review of intrauterine drug therapy.
  • Analysis of current and future therapeutic applications.

Main Results:

  • Intrauterine drug therapy is a viable approach for managing fetal and neonatal conditions.

Related Experiment Videos

  • Established experience exists with both surgical and pharmacological intrauterine treatments.

    • Conclusions:

    • Intrauterine drug therapy plays a crucial role in perinatal medicine.
    • Future research directions include intrauterine hematopoietic stem cell transplants and gene therapy for fetal conditions.